SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (5967)11/18/1998 3:51:00 PM
From: Vector1  Read Replies (1) of 9719
 
All VDers,

Any views on NABI one of the largest suppliers of source plasma and specialty plasma. They collect the plasma through 78 collection centers and are in development on a number of proprietary products. The specialty products include H-BIG which provides passive immunity to hepatitis B. The company is highly leveraged with $60 million in subordinated bonds and about $40m in bank debt. They are loosing money and appear to be having production problems. There are 35 million shares. Is this a candidate to short.

V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News